Prostate Cancer
Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract
February 22, 2011
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract
February 22, 2011
Assessing the acceptability and usability of an interactive serious game in aiding treatment decisions for patients with localized prostate cancer - Abstract
February 22, 2011
The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer - Abstract
February 22, 2011
The effects of body mass index on changes in prostate specific antigen levels and prostate volume: Implications for prostate cancer detection - Abstract
February 22, 2011
Prostate cancer screening and informed decision-making: Provider and patient perspectives - Abstract
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of translational aspects of drug development in prostate cancer - Session Highlights
February 22, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Immune targeting in prostate cancer - Session Highlights
February 22, 2011
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: Late toxicity - Abstract
February 21, 2011
Evaluation of prostate specific antigen acceleration for prostate cancer diagnosis - Abstract
February 21, 2011
Comorbidity, treatment and mortality: A population based cohort study of prostate cancer in PCBaSe Sweden - Abstract
February 21, 2011
Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer - Abstract
February 21, 2011
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging - Abstract
February 21, 2011
Predicting 15-year prostate cancer specific mortality after radical prostatectomy - Abstract
February 21, 2011